233 related articles for article (PubMed ID: 1904067)
1. Decrease in skin collagen glycation with improved glycemic control in patients with insulin-dependent diabetes mellitus.
Lyons TJ; Bailie KE; Dyer DG; Dunn JA; Baynes JW
J Clin Invest; 1991 Jun; 87(6):1910-5. PubMed ID: 1904067
[TBL] [Abstract][Full Text] [Related]
2. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer DG; Dunn JA; Thorpe SR; Bailie KE; Lyons TJ; McCance DR; Baynes JW
J Clin Invest; 1993 Jun; 91(6):2463-9. PubMed ID: 8514858
[TBL] [Abstract][Full Text] [Related]
3. Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus.
McCance DR; Dyer DG; Dunn JA; Bailie KE; Thorpe SR; Baynes JW; Lyons TJ
J Clin Invest; 1993 Jun; 91(6):2470-8. PubMed ID: 8514859
[TBL] [Abstract][Full Text] [Related]
4. Age-dependent accumulation of N epsilon-(carboxymethyl)lysine and N epsilon-(carboxymethyl)hydroxylysine in human skin collagen.
Dunn JA; McCance DR; Thorpe SR; Lyons TJ; Baynes JW
Biochemistry; 1991 Feb; 30(5):1205-10. PubMed ID: 1899338
[TBL] [Abstract][Full Text] [Related]
5. Age-related accumulation of Maillard reaction products in human articular cartilage collagen.
Verzijl N; DeGroot J; Oldehinkel E; Bank RA; Thorpe SR; Baynes JW; Bayliss MT; Bijlsma JW; Lafeber FP; Tekoppele JM
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):381-7. PubMed ID: 10947951
[TBL] [Abstract][Full Text] [Related]
6. Caloric restriction decreases age-dependent accumulation of the glycoxidation products, N epsilon-(carboxymethyl)lysine and pentosidine, in rat skin collagen.
Cefalu WT; Bell-Farrow AD; Wang ZQ; Sonntag WE; Fu MX; Baynes JW; Thorpe SR
J Gerontol A Biol Sci Med Sci; 1995 Nov; 50(6):B337-41. PubMed ID: 7583789
[TBL] [Abstract][Full Text] [Related]
7. Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts.
Lyons TJ; Silvestri G; Dunn JA; Dyer DG; Baynes JW
Diabetes; 1991 Aug; 40(8):1010-5. PubMed ID: 1907246
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a glycemic threshold for the formation of pentosidine in diabetic dog lens but not in collagen.
Nagaraj RH; Kern TS; Sell DR; Fogarty J; Engerman RL; Monnier VM
Diabetes; 1996 May; 45(5):587-94. PubMed ID: 8621008
[TBL] [Abstract][Full Text] [Related]
9. Skin collagen pentosidine and fluorescence in diabetes were predictors of retinopathy progression and creatininemia increase already 6years after punch-biopsy.
Sternberg M; M'bemba J; Urios P; Borsos AM; Selam JL; Peyroux J; Slama G
Clin Biochem; 2016 Feb; 49(3):225-31. PubMed ID: 26506116
[TBL] [Abstract][Full Text] [Related]
10. Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.
Sell DR; Lapolla A; Odetti P; Fogarty J; Monnier VM
Diabetes; 1992 Oct; 41(10):1286-92. PubMed ID: 1397702
[TBL] [Abstract][Full Text] [Related]
11. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
Odetti P; Traverso N; Cosso L; Noberasco G; Pronzato MA; Marinari UM
Diabetologia; 1996 Dec; 39(12):1440-7. PubMed ID: 8960824
[TBL] [Abstract][Full Text] [Related]
12. Two fluorescent wavelengths, 440(ex)/520(em) nm and 370(ex)/440(em) nm, reflect advanced glycation and oxidation end products in human skin without diabetes.
Beisswenger PJ; Howell S; Mackenzie T; Corstjens H; Muizzuddin N; Matsui MS
Diabetes Technol Ther; 2012 Mar; 14(3):285-92. PubMed ID: 22023375
[TBL] [Abstract][Full Text] [Related]
13. The Maillard reaction in vivo.
Dyer DG; Blackledge JA; Katz BM; Hull CJ; Adkisson HD; Thorpe SR; Lyons TJ; Baynes JW
Z Ernahrungswiss; 1991 Feb; 30(1):29-45. PubMed ID: 1858426
[TBL] [Abstract][Full Text] [Related]
14. Glycation, glycoxidation, and cross-linking of collagen by glucose. Kinetics, mechanisms, and inhibition of late stages of the Maillard reaction.
Fu MX; Wells-Knecht KJ; Blackledge JA; Lyons TJ; Thorpe SR; Baynes JW
Diabetes; 1994 May; 43(5):676-83. PubMed ID: 8168645
[TBL] [Abstract][Full Text] [Related]
15. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbA1c as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial.
Monnier VM; Bautista O; Kenny D; Sell DR; Fogarty J; Dahms W; Cleary PA; Lachin J; Genuth S
Diabetes; 1999 Apr; 48(4):870-80. PubMed ID: 10102706
[TBL] [Abstract][Full Text] [Related]
16. Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.
Degenhardt TP; Fu MX; Voss E; Reiff K; Neidlein R; Strein K; Thorpe SR; Baynes JW; Reiter R
Diabetes Res Clin Pract; 1999 Feb; 43(2):81-9. PubMed ID: 10221660
[TBL] [Abstract][Full Text] [Related]
17. Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes.
Genuth S; Sun W; Cleary P; Sell DR; Dahms W; Malone J; Sivitz W; Monnier VM;
Diabetes; 2005 Nov; 54(11):3103-11. PubMed ID: 16249432
[TBL] [Abstract][Full Text] [Related]
18. Advanced glycation end-products and methionine sulphoxide in skin collagen of patients with type 1 diabetes.
Yu Y; Thorpe SR; Jenkins AJ; Shaw JN; Sochaski MA; McGee D; Aston CE; Orchard TJ; Silvers N; Peng YG; McKnight JA; Baynes JW; Lyons TJ;
Diabetologia; 2006 Oct; 49(10):2488-98. PubMed ID: 16955213
[TBL] [Abstract][Full Text] [Related]
19. Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo.
Dyer DG; Blackledge JA; Thorpe SR; Baynes JW
J Biol Chem; 1991 Jun; 266(18):11654-60. PubMed ID: 1904867
[TBL] [Abstract][Full Text] [Related]
20. Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes.
Monnier VM; Sun W; Gao X; Sell DR; Cleary PA; Lachin JM; Genuth S;
Cardiovasc Diabetol; 2015 Sep; 14():118. PubMed ID: 26341632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
